Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). [electronic resource]
Producer: 20060504Description: 30-3 p. digitalISSN:- 0010-7824
- Adolescent
- Adult
- Blood Pressure
- Contraceptives, Oral -- adverse effects
- Ethinyl Estradiol -- administration & dosage
- Female
- Humans
- Menstrual Cycle -- drug effects
- Menstruation Disturbances -- drug therapy
- Norpregnenes -- administration & dosage
- Pregnancy
- Prospective Studies
- Uterine Hemorrhage -- epidemiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.